US Pharm. 2011;36(6)(Generic Drug Review suppl):3.
Greenstone LLC, the generic pharmaceutical subsidiary of Pfizer Inc., announced the introduction of exemestane tablets to its generic pharmaceutical product line. Exemestane is the authorized generic of, and is fully substitutable for, Aromasin. This new generic product from Greenstone is being offered in 25-mg tablets, available in bottles of 30 tablets.
Greenstone LLC also announced the introduction of latanoprost to its generic pharmaceutical product line. Latanoprost is the authorized generic of, and is thereby fully substitutable for, Xalatan. This new generic product from Greenstone is being offered in 125-mcg/2.5-mL solution, available in single-count and three-count cartons.
